Fact CheckerSign in

NCT04791826Completed

Electronic Alerts for Heart Failure Prevention in Diabetes

Evaluation of an EMR-Based Clinical Decision Support Tool for the Implementation of Guideline-Directed Therapies for Prevention of Heart Failure Among High-Risk Patients With Type 2 Diabetes

Source: ClinicalTrials.gov · Last updated 6 Jun 2024

Brief summary (registry, in English)

Type 2 diabetes mellitus (T2DM) is an independent risk factor for heart failure (HF) and is associated with significant morbidity and mortality. Recent therapeutic advances in pharmacotherapies, such as sodium-glucose cotransporter-2 inhibitors (SGLT2i), have shown to be beneficial in preventing HF among patients with T2DM. However, despite widely available risk prediction and stratification tools and evidence-based practice guidelines, SGLT-2i medications are under-prescribed in the United States. The proposed study is a pragmatic, single-center, randomized trial to test the feasibility and effectiveness of a clinical decision support (CDS) tool to alert providers and improve HF risk stratification in patients with T2DM.

Status (registry)
Completed
Study type
Interventional
Enrollment
1524 (actual)
First submitted
5 Mar 2021
Start date
25 Mar 2021
Primary completion date
31 Jul 2022
Lead sponsor
University of Texas Southwestern Medical Center
NCT number
NCT04791826

What you commit to

  • Study type: Interventional
  • Participants enrolled: 1524
  • From 25 Mar 2021 to the primary completion date, 31 Jul 2022
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Providers in an inpatient hospital encounter
  • Patients with HF or on SGLT-2i

Who the study is looking for

  • Providers in a General Internal Medicine outpatient clinic encounter
  • Providers in a subspecialty Internal Medicine outpatient clinic encounter
  • Providers in family medicine outpatient clinic encounter

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Texas Southwestern Medical Center
Coordinator of this site? Confirm its status
DallasUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.